首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid Algorithm.
【24h】

Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid Algorithm.

机译:使用非参数自适应网格算法在健康志愿者中进行瑞格列奈的群体药代动力学建模。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To estimate population pharmacokinetic parameters of repaglinide in 121 healthy Malaysian volunteers. METHODS: Each subject received 4 mg of oral repaglinide. Six blood samples were taken per individual (0, 30, 60, 120, 180 and 240 min) for repaglinide's serum concentration determination by using high-performance liquid chromatography. The parametric Iterative Two-Stage Bayesian Population Model (it2b) program followed by the Non-Parametric Adaptive Grid (npag) program was used to determine a population pharmacokinetic modelling of repaglinide. RESULTS: Using the npag program, the mean elimination rate constant (k(el)) of repaglinide was 0.58 +/- 0.27 h and the volume of distribution (V(d)) was 23.09 +/- 9.19 L/h. CONCLUSION: In this first report, specifically on the population pharmacokinetic modelling of repaglinide, the data generated should help us to better understand appropriate dosage-regimens for the drug.
机译:目的:估计121名马来西亚健康志愿者中瑞格列奈的总体药代动力学参数。方法:每个受试者接受4 mg口服瑞格列奈。每个人(0、30、60、120、180和240分钟)采集六份血液样本,通过使用高效液相色谱法测定瑞格列奈的血清浓度。使用参数迭代两阶段贝叶斯人口模型(it2b)程序,然后使用非参数自适应网格(npag)程序来确定瑞格列奈的人口药代动力学模型。结果:使用npag程序,瑞格列奈的平均消除速率常数(k(el))为0.58 +/- 0.27 h,分布体积(V(d))为23.09 +/- 9.19 L / h。结论:在第一份报告中,特别是关于瑞格列奈的群体药代动力学模型,所产生的数据应有助于我们更好地了解该药物的适当剂量方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号